AAAAAA

   
Results: 1-10 |
Results: 10
PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS IN PLASMAOF PREMATURE AND TERM NEWBORNS
Authors: ASTEDT B LINDOFF C
Citation: B. Astedt et C. Lindoff, PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS IN PLASMAOF PREMATURE AND TERM NEWBORNS, Acta paediatrica, 86(1), 1997, pp. 111-113
PREECLAMPSIA IS ASSOCIATED WITH A REDUCED RESPONSE TO ACTIVATED PROTEIN-C
Authors: LINDOFF C INGEMARSSON I MARTINSSON G SEGELMARK M THYSELL H ASTEDT B
Citation: C. Lindoff et al., PREECLAMPSIA IS ASSOCIATED WITH A REDUCED RESPONSE TO ACTIVATED PROTEIN-C, American journal of obstetrics and gynecology, 176(2), 1997, pp. 457-460
TRANSDERMAL ESTROGEN REPLACEMENT THERAPY - BENEFICIAL-EFFECTS ON HEMOSTATIC RISK-FACTORS FOR CARDIOVASCULAR-DISEASE
Authors: LINDOFF C PETERSON F LECANDER I MARTINSSON G ASTEDT B
Citation: C. Lindoff et al., TRANSDERMAL ESTROGEN REPLACEMENT THERAPY - BENEFICIAL-EFFECTS ON HEMOSTATIC RISK-FACTORS FOR CARDIOVASCULAR-DISEASE, Maturitas, 24(1-2), 1996, pp. 43-50
TISSUE-PLASMINOGEN ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 INSTROKE PATIENTS
Authors: LINDGREN A LINDOFF C NORRVING B ASTEDT B JOHANSSON BB
Citation: A. Lindgren et al., TISSUE-PLASMINOGEN ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 INSTROKE PATIENTS, Stroke, 27(6), 1996, pp. 1066-1071
REDUCTION OF MENSTRUAL BLOOD-LOSS IN WOMEN SUFFERING FROM IDIOPATHIC MENORRHAGIA WITH A NOVEL ANTIFIBRINOLYTIC DRUG (KABI-2161)
Authors: EDLUND M ANDERSSON K RYBO G LINDOFF C ASTEDT B VONSCHOULTZ B
Citation: M. Edlund et al., REDUCTION OF MENSTRUAL BLOOD-LOSS IN WOMEN SUFFERING FROM IDIOPATHIC MENORRHAGIA WITH A NOVEL ANTIFIBRINOLYTIC DRUG (KABI-2161), British journal of obstetrics and gynaecology, 102(11), 1995, pp. 913-917
TREATMENT WITH A GNRH ANALOG - EFFECTS ON HEMOSTATIC RISK-FACTORS FORTHROMBOEMBOLIC DISEASE
Authors: LINDOFF C PETERSSON F SAMSIOE G ASTEDT B
Citation: C. Lindoff et al., TREATMENT WITH A GNRH ANALOG - EFFECTS ON HEMOSTATIC RISK-FACTORS FORTHROMBOEMBOLIC DISEASE, International journal of fertility and menopausal studies, 39(3), 1994, pp. 133-139
PLASMINOGEN-ACTIVATOR OF UROKINASE-TYPE AND ITS INHIBITOR OF PLACENTAL TYPE IN HYPERTENSIVE PREGNANCIES AND IN INTRAUTERINE GROWTH-RETARDATION - POSSIBLE MARKERS OF PLACENTAL FUNCTION
Authors: LINDOFF C ASTEDT B
Citation: C. Lindoff et B. Astedt, PLASMINOGEN-ACTIVATOR OF UROKINASE-TYPE AND ITS INHIBITOR OF PLACENTAL TYPE IN HYPERTENSIVE PREGNANCIES AND IN INTRAUTERINE GROWTH-RETARDATION - POSSIBLE MARKERS OF PLACENTAL FUNCTION, American journal of obstetrics and gynecology, 171(1), 1994, pp. 60-64
PASSAGE OF THE MENOPAUSE IS FOLLOWED BY HEMOSTATIC CHANGES
Authors: LINDOFF C PETERSSON F LECANDER I MARTINSSON G ASTEDT B
Citation: C. Lindoff et al., PASSAGE OF THE MENOPAUSE IS FOLLOWED BY HEMOSTATIC CHANGES, Maturitas, 17(1), 1993, pp. 17-22
TREATMENT WITH TRANEXAMIC ACID DURING PREGNANCY, AND THE RISK OF THROMBOEMBOLIC COMPLICATIONS
Authors: LINDOFF C RYBO G ASTEDT B
Citation: C. Lindoff et al., TREATMENT WITH TRANEXAMIC ACID DURING PREGNANCY, AND THE RISK OF THROMBOEMBOLIC COMPLICATIONS, Thrombosis and haemostasis, 70(2), 1993, pp. 238-240
FIBRINOLYTIC COMPONENTS IN INDIVIDUAL CONSECUTIVE PLASMA SAMPLES DURING NORMAL-PREGNANCY
Authors: LINDOFF C LECANDER I ASTEDT B
Citation: C. Lindoff et al., FIBRINOLYTIC COMPONENTS IN INDIVIDUAL CONSECUTIVE PLASMA SAMPLES DURING NORMAL-PREGNANCY, Fibrinolysis, 7(3), 1993, pp. 190-194
Risultati: 1-10 |